Greene v. Aurobindo Pharma USA, Inc. et al
| Elie D. Greene |
| Aurobindo Pharma USA, Inc., Aurobindo Pharma LTD, Aurobindo, Inc. and John Doe Entities 1-7 |
| 1:2021cv00555 |
| February 5, 2021 |
| US District Court for the Northern District of Georgia |
| Thomas W Thrash |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. ยง 1441 |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on February 23, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| New Civil Action Number in USDC NJ 1:21-cv-3214 (aar) |
| Filing 9 Letter from Clerk re: LR 83.1 Pro Hac Vice requirements sent to Brandon Marcellus Price-Crum. Clerk to follow-up by 3/4/2021. (cdg) |
| Case electronically transferred to District of New Jersey for MDL 2875 (ah) |
| Filing 10 CONDITIONAL TRANSFER ORDER CTO-36 from the Judicial Panel on Multidistrict Litigation TRANSFERRING action to USDC District of New Jersey for MDL 2875 (ah) |
| Civil Case Terminated. (ah) |
Filing 8
ORDER granting #7 Motion to Stay. It is ORDERED that all proceedings in this matter are stayed until the JPML rules on the transfer. Signed by Judge Thomas W. Thrash, Jr. on 2/12/2021. (jpk)
|
| Filing 7 Emergency MOTION to Stay Proceedings Pending a Decision by the Judicial Panel on Multidistrict Litigation with Brief In Support by Aurobindo Pharma USA, Inc.. (Attachments: #1 Exhibit Exhibit A, #2 Exhibit Exhibit B, #3 Brief Defendant's Memorandum of Law in Support of the Emergency Motion to Stay Proceedings, #4 Exhibit Exhibit A, #5 Exhibit Exhibit B, #6 Text of Proposed Order Order)(Celestine, Josanne) |
| Filing 6 NOTICE Of Filing by Aurobindo Pharma USA, Inc. Application for Admission Pro Hac Vice (Celestine, Josanne) |
| Filing 5 NOTICE Of Filing by Aurobindo Pharma LTD Application for Admission Pro Hac Vice (Celestine, Josanne) |
| Filing 4 NOTICE Of Filing by Aurobindo Pharma LTD Application for Admission Pro Hac Vice (Celestine, Josanne) |
| Clerks Notation re #3 Corporate Disclosure Statement approved by Judge Thomas W. Thrash, Jr. (smj) |
| Filing 3 Corporate Disclosure Statement by Aurobindo Pharma USA, Inc. identifying Other Affiliate Aurolife Pharma, LLC for Aurobindo Pharma USA, Inc. by Aurobindo Pharma USA, Inc..(kt) |
|
Filing 2
TENTH AMENDED GENERAL ORDER IN RE: COURT OPERATIONS UNDER EXIGENT CIRCUMSTANCES CREATED BY COVID-19 AND RELATED CORONAVIRUS. Signed by Judge Thomas W. Thrash, Jr. on 1/27/2021. (kt)
|
| Filing 1 NOTICE OF REMOVAL with COMPLAINT filed by Aurobindo Pharma USA, Inc. (Filing fee $ 402 receipt number AGANDC-10696113). (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Civil Cover Sheet)(kt) Please visit our website at http://www.gand.uscourts.gov/commonly-used-forms to obtain Pretrial Instructions and Pretrial Associated Forms which includes the Consent To Proceed Before U.S. Magistrate form. |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Georgia Northern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
